Updated efficacy and safety of avelumab in metastatic urothelial carcinoma (mUC): Pooled analysis from 2 cohorts of the phase 1b Javelin solid tumor study.

被引：16

作者：

Apolo, Andrea B.

Ellerton, John Allan

Infante, Jeffrey R.

Agrawal, Manish

Gordon, Michael S.

Aljumaily, Raid

Britten, Carolyn D.

Dirix, Luc Yves

Lee, Keun-Wook

Taylor, Matthew H.

Schoffski, Patrick

Wang, Ding

Ravaud, Alain

Gelb, Arnold

Xiong, Junyuan

Rosen, Galit

Patel, Manish R.

机构：

[1] NIH, Genitourinary Malignancies Branch, Ctr Canc Res, Natl Canc Inst, Bldg 10, Bethesda, MD 20892 USA

[2] Nevada Canc Res Fdn, Las Vegas, NV USA

[3] Sarah Cannon Res Inst, Nashville, TN USA

[4] Tennessee Oncol PLLC, Nashville, TN USA

[5] Associates Oncol, Rockville, MD USA

[6] Virginia G Piper Canc Ctr, HonorHlth Res Inst Clin Trials Program, Pinnacle Oncol Hematol, Scottsdale, AZ USA

[7] Univ Oklahoma, Med Ctr, Oklahoma City, OK USA

[8] Med Univ South Carolina, Charleston, SC 29425 USA

[9] Sint Augustinus Hosp, Antwerp, Belgium

[10] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea

[11] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USA

[12] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium

[13] Henry Ford Hlth Syst, Detroit, MI USA

[14] Grp Hosp St Andre, Hop St Andre, Bordeaux, France

[15] EMD Serono Inc, Billerica, MA USA

[16] Florida Canc Specialists & Res Inst, Sarasota, FL USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.4528

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

4528

引用

页数：6